Multiple Sclerosis Society of Canada | ClinicalTrials HQ

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Cannabis (THC vs. CBD) in Multiple Sclerosis	CNS demyelinating autoimmune disease, Chemically-Induced Disorders, autoimmune disease, autoimmune disorder of the nervous system, cannabis dependence, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder, psychiatric disorder, substance-related disorder	Recruiting	Phase 2	2026-09-15		NCT06261489
Exercise Training for People With Advanced Multiple Sclerosis	CNS demyelinating autoimmune disease, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder	Not yet recruiting	Not applicable	2026-04-23		NCT07546721
Methionine Intake Microbiota	Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms	Recruiting	Not applicable	2025-12-22		NCT07283328
A Phase I Double Blind Study of Metformin Acting on Endogenous Neural Progenitor Cells in Children and Young Adults With Multiple Sclerosis	CNS demyelinating autoimmune disease, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder	Recruiting	Phase 1 / Phase 2	2025-09-23		NCT04121468
Cannabis as a Complementary Treatment in Multiple Sclerosis	CNS demyelinating autoimmune disease, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder	Recruiting	Phase 2	2024-12-13		NCT05092191
EMG Biofeedback Training to Improve Balance in Individuals with Multiple Sclerosis	CNS demyelinating autoimmune disease, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder	Recruiting	Not applicable	2024-12-03		NCT06461741